Browsing by Sponsor/Funder Parkinson's UK

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 33  next >
Issue DateTitleAuthor(s)
10-Dec-2015Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategyKovacs, GG; Ferrer, I; Grinberg, LT; Alafuzoff, I; Attems, J, et al
18-Apr-2016alpha-synuclein genetic variability: a biomarker for dementia in parkinson diseaseGuella, I; Evans, DM; Szu-Tu, C; Nosova, E; Bortnick, SF, et al
Jul-2020B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosisReali, C; Magliozzi, R; Roncaroli, F; Nicholas, R; Howell, OW, et al
7-Dec-2015Bringing CLARITY to the human brain: visualization of Lewy pathology in three dimensionsLiu, AKL; Hurry, MED; Ng, OTW; DeFelice, J; Lai, HM, et al
19-Feb-2018C-terminal calcium binding of alpha-synuclein modulates synaptic vesicle interactionLautenschlager, J; Stephens, AD; Fusco, G; Strohl, F; Curry, N, et al
22-Jun-2017Chemical probes for visualizing intact animal and human brain tissueLai, HM; Ng, W-L; Gentleman, SM; Wu, W;
Jun-2016Clinicopathological investigations of the cholinergic basal forebrain in Lewy body disorders and ageingGentleman, Steve; Pearce, Ronald; Chang, Raymond Chuen-Chung; Liu, Alan King Lun;
22-Jun-2016Complement is activated in progressive multiple sclerosis cortical grey matter lesions.Watkins, LM; Neal, JW; Loveless, S; Michailidou, I; Ramaglia, V, et al
3-Nov-2015Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases.Ruffmann, C; Calboli, FC; Bravi, I; Gveric, D; Curry, LK, et al
22-Sep-2015Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonismPrusiner, SB; Woerman, AL; Mordes, DA; Watts, JC; Rampersaud, R, et al
19-Apr-2017Free-of-acrylamide SDS-based Tissue Clearing (FASTClear): A novel protocol of tissue clearing for three-dimensional visualisation of human brain tissuesLiu, K; Lai, HM; Chang, RCC; Gentleman, S; , et al
1-Feb-2021Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association studyJabbari, E; Koga, S; Valentino, RR; Reynolds, RH; Ferrari, R, et al
Aug-2014In vivo assessment of pathology in Parkinson’s disease with Positron Emission TomographyBrooks, David; Simpson, Benjamin;
1-Apr-2018Inflammatory intrathecal profiles and cortical damage in multiple sclerosisMagliozzi, R; Howell, OW; Nicholas, R; Cruciani, C; Castellaro, M, et al
13-Jan-2017Jmjd2c facilitates the assembly of essential enhancer-protein complexes at the onset of embryonic stem cell differentiationTomaz, RA; Harman, JL; Karimlou, D; Weavers, L; Fritsch, L, et al
25-Jul-2015Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's diseaseNiccolini, F; Foltynie, T; Marques, TR; Muhlert, N; Tziortzi, AC, et al
16-Dec-2016Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.Martin-Bastida, A; Lao-Kaim, NP; Loane, C; Politis, M; Roussakis, AA, et al
1-Mar-2019Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse linesWoerman, AL; Oehler, A; Kazmi, SA; Lee, J; Halliday, GM, et al
6-Oct-2015Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitorsGautier, HOB; Evans, KA; Volbracht, K; James, R; Sitnikov, S, et al
1-Feb-2021Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre studyAttems, J; Toledo, JB; Walker, L; Gelpi, E; Gentleman, S, et al